Form 4: Cencora Executive Chairman Steven H. Collis Executes Stock Option and Sells Shares

Cencora's Executive Chairman, Steven H. Collis, exercised stock options and sold shares on November 19, 2024, according to a recent SEC filing.

Summary

• Steven H. Collis, the Executive Chairman of Cencora, Inc., exercised non-qualified stock options to acquire 21,509 shares of common stock at a price of $89.58 per share on November 19, 2024.
• On the same day, Mr. Collis sold 21,509 shares of common stock at a price of $242.16 per share.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan established on December 18, 2023.
• Following these transactions, Mr. Collis still directly owns 306,751.665 shares of Cencora common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine insider transaction, which is neither positive nor negative for the company's overall performance. It's a neutral event.

Industry Context

This filing is a routine disclosure of insider transactions and is common for executives of publicly traded companies. The use of a 10b5-1 plan indicates a pre-planned strategy for stock transactions.

Comparison to Industry Standards

• The use of Rule 10b5-1 trading plans is a common practice among executives at publicly traded companies like Cencora, including peers such as McKesson and Cardinal Health, to avoid accusations of insider trading.
• The reported transactions are typical for executives who receive stock options as part of their compensation packages.
• The timing and volume of the transactions are within the expected range for executives managing their personal portfolios.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are part of a pre-planned trading strategy and do not indicate a change in the executive's confidence in the company.

Key Dates

Keywords

Cencora, Steven H. Collis, stock options, share sale, Rule 10b5-1, insider trading, executive chairman, SEC Form 4